Cargando…
Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018
Regulatory agencies around the world have been using flexible requirements for approval of new drugs, especially for cancer drugs. The US Food and Drug Administration (FDA) is mostly the first agency to approve new drugs worldwide, mainly due to the faster terms of the accelerated pathway and breakt...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380631/ https://www.ncbi.nlm.nih.gov/pubmed/32706800 http://dx.doi.org/10.1371/journal.pone.0236345 |